Stay updated on PCSK9 Inhibitors in HoFH Clinical Trial
Sign up to get notified when there's something new on the PCSK9 Inhibitors in HoFH Clinical Trial page.

Latest updates to the PCSK9 Inhibitors in HoFH Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedThe site footer’s revision identifier changed from v3.7.2 to v3.8.0; the study record content remains unchanged.SummaryDifference0.1%

- Check22 days agoChange DetectedA banner announces an NIH website transition and says federal agencies are using “Super Intelligence” in place of “Artificial Intelligence” during the transition.SummaryDifference0.8%

- Check29 days agoChange DetectedThe ClinicalTrials.gov footer now displays revision v3.7.2 instead of v3.7.1.SummaryDifference0.1%

- Check36 days agoChange DetectedThe website’s revision label changes from v3.7.0 to v3.7.1.SummaryDifference0.1%

- Check57 days agoChange DetectedA new revision entry v3.7.0 appears in the record history, indicating an updated version of the study record, while the previous revision v3.6.6 has been removed from the history.SummaryDifference0.1%

- Check78 days agoChange DetectedA new revision tag v3.6.6 appears in the Record History, replacing the earlier v3.6.5. This signals a minor update to the page metadata for the study record.SummaryDifference0.1%

Stay in the know with updates to PCSK9 Inhibitors in HoFH Clinical Trial
Enter your email address, and we'll notify you when there's something new on the PCSK9 Inhibitors in HoFH Clinical Trial page.